Abstract:A drug design pipeline that considers both thermodynamic and kinetic binding data of ligands against a receptor will enable the computational design of improved drug molecules. Here we studied a congeneric set of ligands that bind to structurally unresolved G protein coupled receptor (GPCR), the inactive human adenosine A3 receptor (hA3R). We tested three available homology models from which two have been generated from experimental structures of hA1R or hA2AR and one model was a multi-state alpha-fold2 (AF2)-derived model. We then applied alchemical calculations with thermodynamic integration coupled to MD simulations (TI/MD) to calculate the experimental relative binding free energies, and residence time (τ)-random accelerated MD simulations (τ-RAMD) to calculate the relative residence times (RTs) for antagonists. While the TI/MD calculations produce for the three homology models good Pearson correlation coefficient, correspondingly, r = 0.74, 0.62, 0.67 and mean unsigned error (mue) = 0.94, 1.31, 0.81 kcal mol-1 the τ-RAMD method showed r = 0.92, 0.52 for the first two models but failed to produce accurate results for the multi-state AF2-derived model. Subsequent optimization of the AF2-derived model by re-orientation of side chain of R1735.34 located in the extracellular loop 2 (EL2), that blocks ligand’s unbinding, the computational model showed r = 0.84 for kinetic data and improved performance for thermodynamic data (r = 0.81, mue = 0.56 kcal mol-1). Overall, after refining the multi state-AF2 model with physics-based tools, we were able to show strong correlation between predicted and experimental ligand relative residence times and affinities, achieving a level of accuracy comparable to an experimental structure. The computational workflow used can be applied to other receptor so helping to rank candidate drugs in a congeneric series, enabling prioritization of leads with stronger binding affinities and longer residence times.

Adenosine A 2A receptor agonists: CoMFA-based selection of the most predictive conformation

Pharmacophore Modeling of Human Adenosine Receptor A2A Antagonists

Insights into binding modes of adenosine A2B antagonists with ligand-based and receptor-based methods

Comparison of the Selectivity of Human Adenosine Receptor Antagonists Based on Structure and Pharmacophore Features

Comparative Pharmacophore Modeling of Human Adenosine Receptor A1 and A3 Antagonists

Adenosine A 2A Receptor (A 2A AR) Ligand Screening Using the 19 F-NMR Probe FPPA

Machine Learning for Discovery of New ADORA Modulators

Screening and toxicity evaluation of natural compounds as adenosine 2a and 2b receptor ligands: insights from molecular docking, dynamics, and ADMET analysis

Comparative molecular field analysis of fenoterol derivatives: A platform towards highly selective and effective β2-adrenergic receptor agonists

Activation of the A2A adenosine G-protein-coupled receptor by conformational selection

A Computational Workflow for Refining AF2 Models in Drug Design Using Kinetic and Thermodynamic Binding Calculations: A Case Study for the Unresolved Inactive human Adenosine A3 Receptor

2-Substituted (N)-Methanocarba A3 Adenosine Receptor Agonists: In Silico, In Vitro, and In Vivo Characterization

Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors

Novel selective antagonist radioligands for the pharmacological study of A2B adenosine receptors

The Discovery of Novel α2a Adrenergic Receptor Agonists Only Coupling to Gαi/O Proteins by Virtual Screening

Synthesis and biological evaluation of sugar-modified truncated carbanucleosides as A 2A and A 3 adenosine receptor ligands to explore conformational effect to the receptors

QSAR Analysis of Human Adenosine A3 Receptor Antagonists

Designing Chromane Derivatives as α 2A -Adrenoceptor Selective Agonists via Conformation Constraint

Comparison of A4 and A2a binding sites in striatum and COS cells transfected with adenosine A2a receptors

Molecular Determinants of CGS21680 Binding to the Human Adenosine A2A Receptor

Probing the binding interactions between perfluoroalkyl carboxylic acids and adenosine A 2A receptors by spectroscopic techniques, molecular simulations and quantum chemistry